321 related articles for article (PubMed ID: 12880300)
21. Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis.
Frühwirth M; Wolf H; Heininger H; Guggenbichler JP; Stehr E
Adv Exp Med Biol; 1995; 371B():777-83. PubMed ID: 7502896
[No Abstract] [Full Text] [Related]
22. Pertussis vaccine: a critique.
Robbins JB; Schneerson R; Keith JM; Miller MA; Kubler-Kielb J; Trollfors B
Pediatr Infect Dis J; 2009 Mar; 28(3):237-41. PubMed ID: 19165133
[TBL] [Abstract][Full Text] [Related]
23. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. I. Antibody level for B pertussis antigens in children without respiratory tract infection symptoms].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):259-68. PubMed ID: 10803255
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
Prince HE; Lapé-Nixon M; Matud J
Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
[TBL] [Abstract][Full Text] [Related]
25. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
[TBL] [Abstract][Full Text] [Related]
26. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis.
Oguchi K; Miyata A; Kazuyama Y; Noda A; Suzuki E; Watanabe M; Nakayama T
J Infect Chemother; 2015 Sep; 21(9):639-46. PubMed ID: 26134278
[TBL] [Abstract][Full Text] [Related]
27. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.
Polewicz M; Gracia A; Garlapati S; van Kessel J; Strom S; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
Vaccine; 2013 Jun; 31(31):3148-55. PubMed ID: 23684829
[TBL] [Abstract][Full Text] [Related]
28. The cellular immune response to Bordetella pertussis in two children with whooping cough.
Hafler JP; Pohl-Koppe A
Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
[TBL] [Abstract][Full Text] [Related]
29. Use of erythromycin to prevent pertussis in newborns of mothers with pertussis.
Granström G; Sterner G; Nord CE; Granström M
J Infect Dis; 1987 Jun; 155(6):1210-4. PubMed ID: 2883239
[TBL] [Abstract][Full Text] [Related]
30. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants.
Leuridan E; Hens N; Peeters N; de Witte L; Van der Meeren O; Van Damme P
Pediatr Infect Dis J; 2011 Jul; 30(7):608-10. PubMed ID: 21206396
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
Gonik B; Puder KS; Gonik N; Kruger M
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994
[TBL] [Abstract][Full Text] [Related]
32. Household contact study of Bordetella pertussis infections.
Deen JL; Mink CA; Cherry JD; Christenson PD; Pineda EF; Lewis K; Blumberg DA; Ross LA
Clin Infect Dis; 1995 Nov; 21(5):1211-9. PubMed ID: 8589145
[TBL] [Abstract][Full Text] [Related]
33. [Vertical transmission of immunity against B. pertussis].
Tripodi V; Liguori G; Capunzo M; D'Eliseo R
Boll Ist Sieroter Milan; 1988; 67(5-6):357-62. PubMed ID: 2908739
[TBL] [Abstract][Full Text] [Related]
34. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
[TBL] [Abstract][Full Text] [Related]
35. Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine.
Oda M; Izumiya K; Sato Y; Hirayama M
J Infect Dis; 1983 Jul; 148(1):138-45. PubMed ID: 6309992
[TBL] [Abstract][Full Text] [Related]
36. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn.
Vilajeliu A; Goncé A; López M; Costa J; Rocamora L; Ríos J; Teixidó I; Bayas JM;
Vaccine; 2015 Feb; 33(8):1056-62. PubMed ID: 25573035
[TBL] [Abstract][Full Text] [Related]
37. Seroepidemiology of pertussis in senior adults.
Neuzil KM; Edwards KM; Reed GW
Clin Infect Dis; 2001 Mar; 32(5):847-8. PubMed ID: 11229862
[No Abstract] [Full Text] [Related]
38. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren.
He Q; Viljanen MK; Olander RM; Bogaerts H; De Grave D; Ruuskanen O; Mertsola J
J Infect Dis; 1994 Sep; 170(3):705-8. PubMed ID: 8077734
[TBL] [Abstract][Full Text] [Related]
39. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.
de Voer RM; van der Klis FR; Nooitgedagt JE; Versteegh FG; van Huisseling JC; van Rooijen DM; Sanders EA; Berbers GA
Clin Infect Dis; 2009 Jul; 49(1):58-64. PubMed ID: 19480581
[TBL] [Abstract][Full Text] [Related]
40. Experimental models for testing "Bordetella pertussis" virulence and immunogenicity.
Alonso JM; Rocancourt M; Le Nin S; Brezin C
Ann Sclavo Collana Monogr; 1986; 3(1-2):319-27. PubMed ID: 2892512
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
